<bill session="110" type="h" number="6433" updated="2013-07-19T22:00:05-04:00">
  <state datetime="2008-07-16">REPORTED</state>
  <status>
    <unknown datetime="2008-07-16"/>
  </status>
  <introduced datetime="2008-07-08"/>
  <titles>
    <title as="introduced" type="short">Animal Generic Drug User Fee Act of 2008</title>
    <title as="reported to house" type="short">Animal Generic Drug User Fee Act of 2008</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to establish a program of fees relating to generic new animal drugs.</title>
  </titles>
  <sponsor id="400308"/>
  <cosponsors>
    <cosponsor id="400018" joined="2008-07-08"/>
    <cosponsor id="400099" joined="2008-07-08"/>
    <cosponsor id="400101" joined="2008-07-10"/>
    <cosponsor id="400110" joined="2008-07-08"/>
    <cosponsor id="400409" joined="2008-07-08"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2008-07-08">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2008-07-08">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
    <action datetime="2008-07-09">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
    <action datetime="2008-07-09">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
    <action datetime="2008-07-16">
      <text>Committee Consideration and Mark-up Session Held.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
    <calendar state="REPORTED" datetime="2008-07-16">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </calendar>
    <action datetime="2008-07-30T13:49:00-04:00">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-805.</text>
    </action>
    <calendar datetime="2008-07-30T13:49:00-04:00" calendar="Union" number="521">
      <text>Placed on the Union Calendar, Calendar No. 521.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, Markup, Reporting"/>
    <committee activity="Referral, Markup, Reporting" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative fees"/>
    <term name="Administrative procedure"/>
    <term name="Animals"/>
    <term name="Appropriations"/>
    <term name="Authorization"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Economics and public finance"/>
    <term name="Electronic government information"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Generic drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government publicity"/>
    <term name="Law"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
    <term name="Sunset legislation"/>
    <term name="Veterinary medicine"/>
  </subjects>
  <amendments/>
  <summary>7/30/2008--Reported to House amended.
Animal Generic Drug User Fee Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.Authorizes appropriations for FY2009-FY2013.Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the generic new animal drug development process and the review of abbreviated applications for such drugs; and (2) the implementation of the authority for and use of generic new animal drug fees.Sets forth the process for developing recommendations to present to Congress for the review of abbreviated applications for generic new animal drugs after FY2013.Terminates the authority to assess and use generic new animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</summary>
</bill>
